Search Within

MSK Grad Students

  1. "Molecular Therapy"
Formats
  1. Meeting Abstract (13)
  2. Journal Article (3)
Groups
  1. GSK Faculty (14)
  2. Center for Hematologic Malignancies (13)
  3. Department of Medicine (13)
  4. Hematologic Malignancies Research (13)
  5. Hematologic Malignancies, Division of (13)
  6. Molecular Pharmacology and Chemistry Program Faculty (13)

More Groups

People
  1. Michel Sadelain (9)
  2. Ashlesha Odak (4)
  3. Justin Eyquem (4)
  4. Anton Dobrin (3)
  5. David Scheinberg (3)
  6. Jorge Mansilla-Soto (3)

More People

Years
  1. 2024 (2)
  2. 2022 (2)
  3. 2021 (3)
  4. 2020 (2)
  5. 2019 (3)
  6. 2018 (1)

More Years

Publications
  1. Molecular Therapy (16)
Publishers
  1. Nature Publishing Group (16)

Results (16)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CAR T-cell-derived TNF drives cytokine release syndrome and enhances M1 macrophage differentiation
    Meeting Abstract

    Lindenbergh, P. L.; Giavridis, T.; Vivier, O.; Lopez, M.; Dobrin, A.; Sadelain, M.
    Molecular Therapy (2024)

    Fulltext@MSK | Save
  • GLUT1 overexpression enhances CAR T cell metabolic fitness and anti-tumor efficacy
    Journal Article

    Shi, Y.; Kotchetkov, I. S.; Dobrin, A.; Hanina, S. A.; Rajasekhar, V. K.; Healey, J. H.; Sadelain, M.
    Molecular Therapy (2024)

    Fulltext@MSK | Save
  • Disruption of H3K9me3-mediated gene silencing augments CAR T cell functional persistence
    Meeting Abstract

    Jain, N.; Zhao, Z.; Koche, R.; Gozlan, Y.; Brocks, D.; Raveh-Sadka, T.; Wells, D.; Dobrin, A.; Shi, Y.; Lopez, M.; more...
    Molecular Therapy (2022)

    Fulltext@MSK | Save
  • Globin vector regulatory elements are active in early hematopoietic progenitor cells
    Journal Article

    Cabriolu, A.; Odak, A.; Zamparo, L.; Yuan, H.; Leslie, C. S.; Sadelain, M.
    Molecular Therapy (2022)

    Fulltext@MSK | Save
  • Incorporation of bacterial immunoevasins to protect cell therapies from host antibody-mediated immune rejection
    Journal Article

    Peraro, L.; Bourne, C. M.; Dacek, M. M.; Akalin, E.; Park, J. H.; Smith, E. L.; Scheinberg, D. A.
    Molecular Therapy (2021)

    Fulltext@MSK | Save
  • Subgenomic flaviviral RNA elements enhance rAAV vector mRNA stability and transduction
    Meeting Abstract

    Meganck, R. M.; Moller-Tank, S.; Liu, J.; Tse, L. V.; Vincent, H. A.; Marzluff, W. F.; Asokan, A.
    Molecular Therapy (2021)

    Fulltext@MSK | Save
  • CAR design and expression determine hyper-proliferative states in TET2 deficient T cells
    Meeting Abstract

    Jain, N.; Zhao, Z.; Iyer, A.; Lopez, M.; Feucht, J.; Koche, R.; Yang, J.; Zhan, Y.; Sadelain, M.
    Molecular Therapy (2021)

    Fulltext@MSK | Save
  • Targetable micropharmacies: Cells that produce small-molecule drugs in situ at the tumor site
    Meeting Abstract

    Gardner, T. J.; Lee, P.; Wijewarnasuriya, D.; Kinarivala, N.; Bourne, C.; Kurtz, K.; Corless, B.; Dacek, M.; Mo, G.; Brentjens, R.; more...
    Molecular Therapy (2020)

    Fulltext@MSK | Save
  • Mechanisms of adoptive T cell micropharmacies
    Meeting Abstract

    Bourne, C.; Gardner, T.; Romero-Pichardo, J.; Lee, P.; Dacek, M.; Tan, D.; Scheinberg, D.
    Molecular Therapy (2020)

    Fulltext@MSK | Save
  • Precision genome editing: Identification of highly efficient and specific guides for CRISPR-Cas9 gene editing in human T cell loci
    Meeting Abstract

    Garner, E.; Donohoue, P.; Lau, E.; Vidal, B.; Settle, A.; Irby, M.; Rotstein, T.; Banh, L.; Toh, M.; Williams, C.; more...
    Molecular Therapy (2019)

    Fulltext@MSK | Save